10x Genomics (TXG) Return on Assets (2019 - 2026)

10x Genomics' Return on Assets history runs 8 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q1 2026 at 10x Genomics, up from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• 10x Genomics' Return on Assets stood at 0.0% in 2022, then plunged by 63 bps to 0.0% in 2023, then advanced by 26 bps to 0.0% in 2024, then soared by 79 bps to 0.0% in 2025, then soared by 48 bps to 0.0% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison